MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-27-0033088
Sttar Mellison Pharmaceuticals Private Limited
Sttar Mellison Pharmaceuticals Private Limited - pharma in Navi Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹37.82 Lakh
▼ 2% YoY
Net profit · FY 2025
₹21,918
Net margin 0.6%
EBITDA · FY 2025
₹79,398
EBITDA margin 2.1%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹50 Lakh
Secured borrowings
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
About Sttar Mellison Pharmaceuticals Private Limited
Data last updated:
Sttar Mellison Pharmaceuticals Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 June 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2016PTC282801. Its GSTIN is 27AAXCS2516B1ZA (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shankar Jagannath Tone and Lalita Vilas Kalel.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Navi Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹37.82 Lakh, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹21,918 (net margin 0.6%) and EBITDA of ₹79,398 (EBITDA margin 2.1%). Revenue has grown at a compounded annual rate (CAGR) of 29% over three years and 14% over five years.
As per MCA filings, the company has open charges of ₹50 Lakh on record.
Sttar Mellison Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-27-0033088). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74999MH2016PTC282801
Registration Number 282801
Incorporation Date 23 June 2016
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-27-0033088
Recognitions & Rankings of Sttar Mellison Pharmaceuticals
Contact details
Sttar Mellison Pharmaceuticals Private Limited's registered office is in Navi Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressUnit No.A/516 5th Floor Silver Spring Plot No.G – 6 Taloja MIDC Industrial Area, Taloja, Navi Mumbai, Maharashtra, India – 410208
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sttar Mellison Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Sttar Mellison Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Sttar Mellison Pharmaceuticals is manufacturing. In detail, this covers manufacture of food products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 10 | Manufacture of food products |
To see the full business activity and turnover split of Sttar Mellison Pharmaceuticals Private Limited, buy the company report.
Financials of Sttar Mellison Pharmaceuticals Private Limited
FY 2024 filings availableSttar Mellison Pharmaceuticals Private Limited reported revenue of ₹37.82 Lakh (down 2% YoY) for FY 2025.
Revenue · FY 2025
₹37.82 Lakh ▼ 2%
Net profit · FY 2025
₹21,918 margin 0.6%
EBITDA · FY 2025
₹79,398 margin 2.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 2%
3 years · compounded
▲ 29%
5 years · compounded
▲ 14%
EBITDA CAGR growth
1 year
▼ 30%
3 years · compounded
▲ 17%
5 years · compounded
▲ 12%
Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 14%. EBITDA fell 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹79,398 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹21,918 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.1% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sttar Mellison Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sttar Mellison Pharmaceuticals Private Limited
Sttar Mellison Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shankar Jagannath Tone | Director | 23 Jun 2016 | 10 Years 4 Months | Current |
| Lalita Vilas Kalel | Director | 23 Jun 2016 | 10 Years 4 Months | Current |
Auditor
Sttar Mellison Pharmaceuticals Private Limited is audited by CA AMRRITA JAGNAANI for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| CA AMRRITA JAGNAANI | FY 2023 | 168037 |
Shareholding
The shareholding of Sttar Mellison Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sttar Mellison Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹50 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Mar 2024 | 100897965 | Others | ₹50 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Sttar Mellison Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sttar Mellison Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sttar Mellison Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAXCS2516B1ZA | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sttar Mellison Pharmaceuticals Private Limited, buy the company report.
Recent activity
Sttar Mellison Pharmaceuticals Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Lalita Vilas Kalel was appointed as Director on 23 Jun 2016.
AGM
Sttar Mellison Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Sttar Mellison Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge with Others amounted to Rs. 50.00 Lakh with Charge ID 100897965 was registered on 26 Mar 2024.
Appointed
Lalita Vilas Kalel was appointed as Director.
Appointed
Shankar Jagannath Tone was appointed as Director.
Incorporation
23 Jun 2016
Sttar Mellison Pharmaceuticals Private Limited was registered on 23 Jun 2016 with Roc Mumbai & aged 10 years 4 months as per MCA records.
Frequently asked questions
Sttar Mellison Pharmaceuticals is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 June 2016 (10+ years old) and is registered under CIN U74999MH2016PTC282801.
Sttar Mellison Pharmaceuticals has 2 current directors:
- Shankar Jagannath Tone - Director
- Lalita Vilas Kalel - Director
The latest financial statements of Sttar Mellison Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Sttar Mellison Pharmaceuticals is 27AAXCS2516B1ZA, registered in Maharashtra.
The CIN (Corporate Identification Number) of Sttar Mellison Pharmaceuticals is U74999MH2016PTC282801. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sttar Mellison Pharmaceuticals was incorporated on 23 June 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
Lalita Vilas Kalel was appointed as Director on 23 Jun 2016. Shankar Jagannath Tone was appointed as Director on 23 Jun 2016.
Yes, Sttar Mellison Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-27-0033088).
The registered office of Sttar Mellison Pharmaceuticals is at Unit No.A516 5th Floor Silver Spring Plot No.G – 6 Taloja MIDC Industrial Area, Taloja, Navi Mumbai, Maharashtra, India – 410208.
Sttar Mellison Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages